Going bald young isn’t bad luck or too much testosterone. It’s written into your genes, and scientists now understand why some hair follicles cave to hormones that other follicles simply shrug off.
Story Snapshot
- Early male-pattern baldness comes from inherited follicle sensitivity to a hormone called DHT, not from having extra DHT in the blood.
- Genetics drive about 80 percent of a man’s risk for baldness, according to twin studies.
- A gene on the X chromosome, tied to the androgen receptor, plays a major role in early-onset hair loss.
- Researchers have found several other gene locations linked to baldness risk, pointing to a complex, inherited trait rather than a single cause.
The Hormone Everyone Blames, Explained Correctly
Dihydrotestosterone, known as DHT, gets blamed for baldness constantly. That blame is only half right. DHT does attach to receptors in scalp hair follicles and shrink them over time, a process doctors call miniaturization. But the real trigger isn’t how much DHT a man has floating in his blood. It’s how his follicles react to normal amounts of it.
A widely cited review puts it plainly. Men with male-pattern hair loss inherit scalp follicles that are unusually sensitive to normal hormone levels, not follicles exposed to abnormal hormone levels. That distinction matters. It means blood tests measuring DHT often fail to separate balding men from men with full heads of hair, because the hormone amount isn’t the deciding factor.
Why Genes, Not Hormone Levels, Call the Shots
Twin studies back this up hard. Researchers estimate that heredity accounts for roughly 80 percent of a man’s risk for both early and late baldness. That leaves relatively little room for lifestyle, diet, or stress to explain why one brother goes bald at 25 while another keeps a full head at 50. The follicles themselves are built differently from birth, based on inherited instructions.
One gene draws special attention. The androgen receptor gene sits on the X chromosome, which men inherit from their mothers. Scientists consider it a leading candidate for triggering early-onset baldness, since it controls how strongly a follicle responds when DHT comes knocking. Balding scalps often show higher receptor activity and more of an enzyme that converts testosterone into DHT locally.
A Trait Built From Many Genes, Not One Switch
Baldness isn’t controlled by a single gene like eye color. Large genetic studies scanning thousands of men have turned up multiple risk locations scattered across different chromosomes. One major analysis compared over 10,000 early-onset cases against controls and confirmed the condition is polygenic, meaning many genes contribute small pieces to the overall risk.
That complexity explains why baldness can skip a generation or show up on unexpected sides of the family tree. A man can’t just look at his father and know his fate. He inherits a mix of variants from both parents, and those variants interact with local scalp signaling in ways researchers are still mapping out gene by gene.
What This Means Beyond the Mirror
Baldness research carries stakes beyond vanity. One widely reported study found men with severe baldness at the crown faced a 5.6 times greater risk of coronary artery disease compared to men with full hair, after adjusting for other risk factors. Premature gray hair carried a similarly elevated risk. Doctors now view scalp changes as a potential early flag worth mentioning at a checkup, not just a cosmetic annoyance.
Men with severe baldness on the top of the head have a 32 percent higher risk of coronary heart disease. A 2013 meta-analysis in BMJ Open combined six studies and 39,000 participants and found that the pattern of hair loss matters: the bald crown is a risk marker, but a receding… pic.twitter.com/16mnJk9laI
— Anish Moonka (@anishmoonka) September 16, 2026
None of this means baldness is untreatable or purely a life sentence handed down at conception. Treatments like topical minoxidil have shown real ability to boost terminal hair growth even in early-stage pattern baldness, working alongside the biology rather than against it. Understanding that the fight is against inherited follicle sensitivity, not blood hormone levels, helps men and their doctors pick treatments grounded in how the condition actually works, instead of chasing the wrong target.
Sources:
menshealth.com, pmc.ncbi.nlm.nih.gov, nature.com, mdpi.com
